Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae
- PMID: 15555834
- PMCID: PMC7135774
- DOI: 10.1016/j.idc.2004.07.010
Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae
Abstract
Pneumonia caused by Streptococcus pneumoniae is the most deadly form of community-acquired pneumonia. The death rate of bacteremic pneumococcal pneumonia has remained constant over the past 50 years. Several retrospective reviews of bacteremic pneumococcal pneumonia suggest that dual therapy with a beta-lactam and a macrolide antimicrobial agent is associated with a lower case fatality rate than therapy with a beta-lactam alone. These studies are reviewed, potential mechanisms are suggested, and future studies are discussed.
References
-
- Austrian R., Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Arch Intern Med. 1964;60:759–776. - PubMed
-
- Marrie T.J. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect. 1992;24:247–255. - PubMed
-
- Ewig S., Torres A. Severe community-acquired pneumococcal pneumonia—what might be done better. Intensive Care Med. 1999;25:143–145. - PubMed
-
- Heffelfinger J.D., Dowell S.F., Jorgensen J.H. Management of community- acquired pneumonia in the era pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae therapeutic working group. Arch Intern Med. 2000;160:1399–1408. - PubMed
-
- Mufson M.A., Stanek R.J. Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997. Am J Med. 1999;107:34S–43S. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
